Literature DB >> 17920582

Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.

Kerem Bulut1, Christian Pennartz, Peter Felderbauer, Juris J Meier, Matthias Banasch, Daniel Bulut, Frank Schmitz, Wolfgang E Schmidt, Peter Hoffmann.   

Abstract

Glucagon like peptide-2 (GLP-2) exerts intestinotrophic actions, but the underlying mechanisms are still a matter of debate. Recent studies demonstrated the expression of the GLP-2 receptor on fibroblasts located in the subepithelial tissue, where it might induce the release of growth factors such as keratinocyte growth factor (KGF) or vascular endothelial growth factor (VEGF). Therefore, in the present studies we sought to elucidate the downstream mechanisms involved in improved intestinal adaptation by GLP-2. Human colonic fibroblasts (CCD-18Co), human colonic cancer cells (Caco-2 cells) and rat ileum IEC-18 cells were used. GLP-2 receptor mRNA expression was determined using real time RT-PCR. Conditioned media from CCD-18Co cells were obtained following incubation with GLP-2 (50-250 nM) for 24 h. Cell viability was assessed by a 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl-tetrazolium bromide (MTT)-assay, and wound healing was determined with an established migration-assay. Transforming Growth Factor beta (TGF-beta), VEGF and KGF mRNA levels were determined by RT-PCR. Protein levels of VEGF and TGF-beta in CCD-18Co cells following GLP-2 stimulation were determined using ELISA. Neutralizing TGF-beta and VEGF-A antibodies were utilized to assess the role of TGF-beta and VEGF-A in the process of wound healing. GLP-2 receptor expression was detected in CCD-18Co cells. Conditioned media from CCD-18Co cells dose-dependently induced proliferation in Caco-2 cells, but not in IEC-18 cells. Conditioned media also enhanced cell migration in IEC-18 cells (P<0.01), while migration was even inhibited in Caco-2 cells (P<0.0012). GLP-2 significantly stimulated mRNA expression of VEGF and TGF-beta, but not of KGF in CCD-18Co. The migratory effects of GLP-2 were completely abolished in the presence of TGF-beta and VEGF-A antibodies. GLP-2 exerts differential effects on the epithelium of the small intestine and the colon. Thus, in small intestinal cells GLP-2 stimulates wound repair, whereas no such effects were observed in colonic cells. The mechanisms underlying GLP-2 induced intestinal wound repair seem to involve the secretion of VEGF and, subsequently, TGF-beta from subepithelial fibroblasts, whereas KGF appeared to be less important.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920582     DOI: 10.1016/j.ejphar.2007.08.044

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Control of Intestinal Epithelial Proliferation and Differentiation: The Microbiome, Enteroendocrine L Cells, Telocytes, Enteric Nerves, and GLP, Too.

Authors:  Jonathan D Kaunitz; Yasutada Akiba
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

2.  Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2009-08-13       Impact factor: 5.590

Review 3.  Stem cells as a potential future treatment of pediatric intestinal disorders.

Authors:  Troy A Markel; Paul R Crisostomo; Tim Lahm; Nathan M Novotny; Frederick J Rescorla; Joseph Tector; Daniel R Meldrum
Journal:  J Pediatr Surg       Date:  2008-11       Impact factor: 2.545

4.  Emerging treatment options for short bowel syndrome: potential role of teduglutide.

Authors:  Cheng T Tee; Katharina Wallis; Simon M Gabe
Journal:  Clin Exp Gastroenterol       Date:  2011-08-19

Review 5.  Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms.

Authors:  Changting Xiao; Priska Stahel; Gary F Lewis
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-11-02

6.  Probiotics Bacillus licheniformis Improves Intestinal Health of Subclinical Necrotic Enteritis-Challenged Broilers.

Authors:  Liugang Kan; Fangshen Guo; Yan Liu; Van Hieu Pham; Yuming Guo; Zhong Wang
Journal:  Front Microbiol       Date:  2021-05-18       Impact factor: 5.640

Review 7.  Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease.

Authors:  Manasvini Markandey; Aditya Bajaj; Nicholas Edward Ilott; Saurabh Kedia; Simon Travis; Fiona Powrie; Vineet Ahuja
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  Toll-like receptor 4 signaling integrates intestinal inflammation with tumorigenesis: lessons from the murine model of colitis-associated cancer.

Authors:  Yasmin Hernandez; John Sotolongo; Masayuki Fukata
Journal:  Cancers (Basel)       Date:  2011-08-02       Impact factor: 6.639

Review 9.  Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization.

Authors:  Changting Xiao; Priska Stahel; Avital Nahmias; Gary F Lewis
Journal:  Front Physiol       Date:  2020-01-29       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.